Home
The Science
Leadership
In the News
Contact Us
More
June 2022
Britecyte’s Research Project “A Mesenchymal Stem Cell Containing Matrix for Nonalcoholic Steatohepatitis (NASH)” was awarded a $270,000 Commercialization Program Grant from the Maryland Stem Cell Research Fund (MSCRF)
